Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?

Trifirò G, Spina E, Gambassi G.

Pharmacol Res. 2009 Jan;59(1):1-12. doi: 10.1016/j.phrs.2008.09.017. Epub 2008 Oct 8. Review.

PMID:
18977443
2.

Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?

Herrmann N, Lanctôt KL.

Drug Saf. 2006;29(10):833-43. Review.

PMID:
16970508
3.
4.

[Atypical antipsychotics in elderly patients with dementia].

Selbaek G, Engedal K.

Tidsskr Nor Laegeforen. 2008 May 1;128(9):1060-1. Norwegian.

5.
6.

Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics.

Liperoti R, Gambassi G, Lapane KL, Chiang C, Pedone C, Mor V, Bernabei R.

J Clin Psychiatry. 2005 Sep;66(9):1090-6.

PMID:
16187764
7.

Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Haddad PM, Sharma SG.

CNS Drugs. 2007;21(11):911-36. Review.

PMID:
17927296
8.

Use and safety of antipsychotics in behavioral disorders in elderly people with dementia.

Gareri P, De Fazio P, Manfredi VG, De Sarro G.

J Clin Psychopharmacol. 2014 Feb;34(1):109-23. doi: 10.1097/JCP.0b013e3182a6096e. Review.

PMID:
24158020
9.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
10.

Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.

Pratt N, Roughead EE, Salter A, Ryan P.

BMC Med Res Methodol. 2012 Jun 8;12:72. Review.

11.

Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events.

van Iersel MB, Zuidema SU, Koopmans RT, Verhey FR, Olde Rikkert MG.

Drugs Aging. 2005;22(10):845-58. Review.

PMID:
16245958
12.

Antipsychotic use in elderly patients and the risk of pneumonia.

Gambassi G, Sultana J, Trifirò G.

Expert Opin Drug Saf. 2015 Jan;14(1):1-6. doi: 10.1517/14740338.2015.984684. Epub 2014 Nov 28.

PMID:
25431005
13.

The use of atypical antipsychotics in the management of schizophrenia.

Campbell M, Young PI, Bateman DN, Smith JM, Thomas SH.

Br J Clin Pharmacol. 1999 Jan;47(1):13-22. Review.

14.

Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia.

Schmedt N, Garbe E.

J Clin Psychopharmacol. 2013 Dec;33(6):753-8. doi: 10.1097/JCP.0b013e3182a412d5.

PMID:
24052055
15.

The efficacy, safety, and tolerability of antipsychotics in the elderly.

Maixner SM, Mellow AM, Tandon R.

J Clin Psychiatry. 1999;60 Suppl 8:29-41. Review.

16.

Paediatric atypical antipsychotic monitoring safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings.

Rani FA, Byrne PJ, Murray ML, Carter P, Wong IC.

Drug Saf. 2009;32(4):325-33. doi: 10.2165/00002018-200932040-00006.

PMID:
19388723
17.

Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy.

Rafaniello C, Lombardo F, Ferrajolo C, Sportiello L, Parretta E, Formica R, Potenza S, Rinaldi B, Irpino A, Raschetti R, Vanacore N, Rossi F, Capuano A.

Eur J Clin Pharmacol. 2014 Feb;70(2):187-95. doi: 10.1007/s00228-013-1588-3. Epub 2013 Oct 22.

PMID:
24145814
18.
19.

Risk of hospitalization for stroke associated with antipsychotic use in the elderly: a self-controlled case series.

Pratt NL, Roughead EE, Ramsay E, Salter A, Ryan P.

Drugs Aging. 2010 Nov 1;27(11):885-93. doi: 10.2165/11584490-000000000-00000.

PMID:
20964462
20.
Items per page

Supplemental Content

Write to the Help Desk